213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Michel Chérel; Sébastien Gouard; Joëlle Gaschet; Catherine Saï-Maurel; Frank Bruchertseifer; Alfred Morgenstern; Mickael Bourgeois; Jean-François Gestin; Françoise Kraeber Bodéré; Jacques Barbet; Philippe Moreau; François Davodeau

doi:10.2967/jnumed.112.111997

Research ArticleBasic Science Investigations

²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Michel Chérel, Sébastien Gouard, Joëlle Gaschet, Catherine Saï-Maurel, Frank Bruchertseifer, Alfred Morgenstern, Mickael Bourgeois, Jean-François Gestin, Françoise Kraeber Bodéré, Jacques Barbet, Philippe Moreau and François Davodeau

Journal of Nuclear Medicine September 2013, 54 (9) 1597-1604; DOI: https://doi.org/10.2967/jnumed.112.111997

Michel Chérel

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

2Nuclear Medicine Department, ICO-René Gauducheau Cancer Center, IRCNA, Saint Herblain, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sébastien Gouard

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joëlle Gaschet

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

2Nuclear Medicine Department, ICO-René Gauducheau Cancer Center, IRCNA, Saint Herblain, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Saï-Maurel

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frank Bruchertseifer

3European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alfred Morgenstern

3European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mickael Bourgeois

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

4Nuclear Medicine Department, University Hospital, Nantes, France; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-François Gestin

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

2Nuclear Medicine Department, ICO-René Gauducheau Cancer Center, IRCNA, Saint Herblain, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Françoise Kraeber Bodéré

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

2Nuclear Medicine Department, ICO-René Gauducheau Cancer Center, IRCNA, Saint Herblain, France

4Nuclear Medicine Department, University Hospital, Nantes, France; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jacques Barbet

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philippe Moreau

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

5Hematology Department, University Hospital, Nantes, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

François Davodeau

1Nantes-Angers Cancer Research Center CRCNA, University of Nantes, INSERM UMR892, CNRS UMR6299, Nantes, France

4Nuclear Medicine Department, University Hospital, Nantes, France; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 54, Issue 9

September 1, 2013

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Journal of Nuclear Medicine Sep 2013, 54 (9) 1597-1604; DOI: 10.2967/jnumed.112.111997

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Journal of Nuclear Medicine Sep 2013, 54 (9) 1597-1604; DOI: 10.2967/jnumed.112.111997

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

TAG-72-Targeted {alpha}-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody
212Pb {alpha}-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study

Google Scholar

Keywords

radioimmunotherapy
α-particle
213Bi
oncology
multiple myeloma
CD138
5T33

Main menu

User menu

Search

²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords